a.boateng
Submits third-party assay reports on material purchased directly. Based in Kaunas.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.80%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042889 | Ipamorelin | GGPeps | GGPE-2508-E2729 | Janoshik | 2026-Q1 | 99.80 | 5.48 | 98.9 | Buyer-sourced | 0 | PASS |
| AX-2026-041375 | Ipamorelin | WWB | WWB-2601-C3477 | PeptideMeter | 2026-Q1 | 99.85 | 5.65 | — | Laboratory-retained | 0 | PASS |
| AX-2026-042096 | MGF | HYB | HYB-2509-X7841 | Janoshik | 2025-Q4 | 99.93 | 2.37 | 95.5 | Buyer-sourced | 0 | PASS |
| AX-2025-020395 | Tirzepatide | MKM | MKM-2411-B3993 | Janoshik | 2025-Q2 | 97.93 | 3.62 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019494 | Liraglutide | JEEP | JEEP-2411-B9021 | Medutest | 2025-Q2 | 99.04 | 4.22 | 93.4 | Buyer-sourced | 1 | FAIL |
| AX-2024-004465 | Semax | AMB | AMB-2411-G5528 | Medutest | 2024-Q4 | 99.93 | 9.85 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005298 | Tirzepatide | BCH | BCH-2404-N5218 | Janoshik | 2024-Q3 | 97.63 | 3.74 | 97.1 | Buyer-sourced | 0 | PASS |